-
2022-502899-23-00
5
2024-04-23
Hepatic Encephalopathy (OHE)
-
2023-506425-12-00
5
2024-04-17
Uncontrolled and Resistant Hypertension
-
2023-504678-39-00
4
2024-03-13
Heart Failure
-
2022-502484-38-00
5
2024-02-07
Type 2 diabetes
-
2022-503013-32-00
4
2024-01-29
ER-positive/HER2-negative early breast cancer
-
2023-505910-10-00
4
2024-01-23
Relapsed or Refractory High-Risk Myelodysplastic Syndrome
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502080-38-00
5
2023-10-16
Moderate to severe rotator cuff tendinopathy
-
2022-501074-19-00
10
2023-10-13
Hidradenitis suppurativa
-
2022-501621-20-00
5
2023-10-02
Prurigo Nodularis
-
2022-502888-38-00
4
2023-09-25
Atopic dermatitis
-
2022-502174-16-00
5
2023-09-13
Macular edema secondary to retinal vein occlusion
-
2022-502382-25-00
4
2023-08-24
Heart Failure and Pulmonary Hypertension due to Left Heart Disease (WH
-
2023-508267-69-00
3
2023-08-11
Subjects with Aadvanced solid tumors for whom life-prolonging therapie
-
2022-502620-49-00
2
2023-08-01
Resected Melanoma Stage III or Stage IV
-
2022-501753-36-00
5
2023-06-02
Hidradenitis Suppurativa
-
2023-504869-23-00
11
2023-05-31
Dermatitis atopic
-
2022-500608-23-00
4
2023-04-06
Previously Untreated MET Amplified Locally Advanced/Metastatic Non-Squ
-
2024-514761-19-00
5
2023-01-25
Idiopathic Pulmonary Fibrosis
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2022-500332-11-00
4
2022-11-25
systemic sclerosis
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2024-512803-37-00
5
2022-10-05
Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
-
2023-505458-16-00
5
2022-09-13
Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpressio